In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID. New research ...

In 2023, 117 cases of multisystem inflammation syndrome in children (MIS-C) were reported, with 26 percent of patients having onset during August to October, according to research published in the ...

It’s one of the enduring mysteries of the pandemic: What caused some children to develop a severe inflammatory syndrome weeks after a Covid infection? The condition is called multi-system inflammatory ...

St. Jude Children's Research Hospital scientists have identified a link between a SARS-CoV-2 protein and the onset of multisystem inflammatory syndrome in children (MIS-C). MIS-C is a pediatric ...

Multisystem inflammatory syndromes in children represent a rare but serious post-infectious hyperinflammatory condition most notably observed in association with SARS-CoV-2. Clinically, affected ...

Early in the pandemic, some children fought off COVID with few, if any, symptoms, only to go into organ failure a few weeks later. Most recovered after aggressive treatment, but their sudden illness, ...

Study reveals a mechanism behind multisystem inflammatory syndrome in children (MIS-C). Early in the COVID-19 pandemic, some children fought off COVID with few, if any, symptoms, only to go into organ ...

Faster resolution of GI symptoms, faster clearance of spike antigen, faster return to usual activities reported for children treated with larazotide. HealthDay News — Treatment of multisystem ...

A woman develops autoimmune/inflammatory syndrome induced by adjuvants after hyaluronic acid filler and hyaluronidase exposure, with biopsy-confirmed acquired cutis laxa.